ArticleFrontiers in immunology2024

HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients.

Shibo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.